Meyka Pro banner
Ocuphire Pharma, Inc.

Stay Updated with the Latest Ocuphire Pharma, Inc. OCUP News in Real Time

Find OCUP news now at Meyka AI. Stay informed with the latest Ocuphire Pharma, Inc. stocks updates, including price news, market analysis, and expert insights.

OCUPNASDAQ
HealthcareBiotechnology
$1.17
$0.16(12.03%)
U.S. Market opens in 14h 27m
Best High ROE Tech Stocks With Strong Growth Potential in 2026
📅 5 hours ago

Best High ROE Tech Stocks With Strong Growth Potential in 2026

Return on Equity (ROE) is one of the first metrics many investors check when assessing technology stocks in 2026. With artificial intelligence, cloud computing, and semiconductor demand driving earnings, companies that generate strong returns from shareholder capital continue to attract attention.  In July 2026, several major tech firms reported solid profits even as they increased…

Read more 12
Generic Zyrtec Recalled Over Heartburn Drug Contamination July 24
📅 3 days ago

Generic Zyrtec Recalled Over Heartburn Drug Contamination July 24

Generic Zyrtec recalled nationwide due to contamination with heartburn drug ranitidine. Four lot numbers affected. No illnesses reported yet. Check your bottles.

Read more 12
Eggs Salmonella Recall: Over 1.5 Million Dozen Eggs Pulled Across Six States
📅 4 days ago

Eggs Salmonella Recall: Over 1.5 Million Dozen Eggs Pulled Across Six States

More than 1.5 million dozen eggs have been recalled across the United States after concerns about possible Salmonella Enteritidis contamination. The voluntary recall, announced by the U.S. Food and Drug Administration (FDA) on July 22, 2026, covers eggs sold in six states through major grocery chains and food-service distributors. If you recently bought eggs, it’s…

Read more 12
Generic Zyrtec Recalled Over Heartburn Drug Mix-Up, July 23
📅 4 days ago

Generic Zyrtec Recalled Over Heartburn Drug Mix-Up, July 23

Generic Zyrtec recalled nationwide for cross-contamination with heartburn drug ranitidine. Four lot numbers affected. No illnesses reported yet. Call Rising Pharma at 1-844-874-7464.

Read more 12
Generic Zyrtec Recalled Over Ranitidine Contamination Risk July 23
📅 4 days ago

Generic Zyrtec Recalled Over Ranitidine Contamination Risk July 23

Generic Zyrtec cetirizine tablets recalled nationwide due to cross-contamination with ranitidine heartburn drug. Four lot numbers affected, expiring October 2028. No adverse events reported yet.

Read more 12
Indian Stocks Q1 Earnings Watch: IEX, Fractal Analytics, Allied Blenders Lead Today’s Results
📅 4 days ago

Indian Stocks Q1 Earnings Watch: IEX, Fractal Analytics, Allied Blenders Lead Today’s Results

Q1 earnings season hits full stride in India on July 23, 2026. Roughly 60 companies report results today, led by Indian Energy Exchange, Fractal Analytics, and Allied Blenders. Infosys, InterGlobe Aviation, and Cipla headline the broader list. Boards at IEX and Fractal Analytics meet today to approve their unaudited Q1 FY27 numbers, while Allied Blenders…

Read more 12
GOOGL Alphabet Earnings Beat Estimates as Cloud Revenue Soars 82%
📅 4 days ago

GOOGL Alphabet Earnings Beat Estimates as Cloud Revenue Soars 82%

On 22 July 2026, Alphabet (NASDAQ: GOOGL) reported stronger-than-expected second-quarter earnings, helped by exceptional growth in its cloud business. Google Cloud revenue jumped 82% year over year, reflecting continued demand for AI services from enterprise customers. The results also showed steady growth in Google’s advertising business despite increasing competition in AI-powered search. While the earnings…

Read more 12
Swedencare (STO: SECARE) Shares Plunge 17% After Q2 Revenue Misses Analyst Estimates
📅 5 days ago

Swedencare (STO: SECARE) Shares Plunge 17% After Q2 Revenue Misses Analyst Estimates

Swedencare shares plunged 17% Wednesday after second-quarter results missed Wall Street expectations. The pet health company reported net sales of SEK 670 million for Q2 2026. That figure grew just 4% year-over-year but missed consensus estimates by 4%. Operational EBITDA reached SEK 129 million, also up 4%, yet fell 5% short of forecasts.  North America…

Read more 12
TSLA Stock in Focus as Tesla Reports Q2 Earnings and Margin Outlook
📅 5 days ago

TSLA Stock in Focus as Tesla Reports Q2 Earnings and Margin Outlook

Tesla (NASDAQ: TSLA) is back in the spotlight as the company gets ready to release its second quarter 2026 earnings on 22 July 2026 after the market closes. The report follows a quarter in which Tesla delivered 480,126 vehicles, raising expectations for solid financial results. Even so, investors are looking well beyond delivery numbers. They…

Read more 12

OCUP News FAQ